Glaukos (GKOS) Total Current Liabilities (2014 - 2026)
Glaukos' (GKOS) quarterly Total Current Liabilities came in at $89.4 million in Q1 2026, up 30.48% year-on-year from $68.5 million in Q1 2025, and down 11.71% on a QoQ basis from $101.3 million in Q4 2025.
Glaukos (GKOS) Total Current Liabilities (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Total Current Liabilities data on file, last reported at $89.4 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 30.48% year-over-year to $89.4 million in Q1 2026; TTM through Mar 2026 was $89.4 million, a 30.48% increase from a year earlier, with the FY2025 full-year figure at $101.3 million, up 34.81% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $89.4 million, down from $101.3 million in the prior quarter.
- Over the last five years, Total Current Liabilities for GKOS reached as high as $101.3 million in Q4 2025 and fell as low as $55.6 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $73.0 million across 5 years, with a median of $71.7 million in 2024.
- Across the five-year window, Total Current Liabilities slumped 83.43% in 2022 and jumped 34.81% in 2025, its largest moves.
- Year by year, Total Current Liabilities stood at $72.4 million in 2022, then grew by 2.29% to $74.0 million in 2023, then gained by 1.5% to $75.1 million in 2024, then surged by 34.81% to $101.3 million in 2025, then decreased by 11.71% to $89.4 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $89.4 million in Q1 2026, $101.3 million in Q4 2025, and $87.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 176.38 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 48.68 Bn | 45.01 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | 2.22 Bn |
| 7 | GE HealthCare Technologies | 28.38 Bn | 26.09 Bn | 1.98 Bn | 8.53 Bn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | 1.60 Bn |
| 9 | Koninklijke Philips | 25.50 Bn | 22.38 Bn | 2.07 Bn | 8.70 Bn |
| 10 | Glaukos | 8.79 Bn | 8.68 Bn | 117.23 Mn | 89.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.42 Mn |
| Dec 31, 2025 | 101.28 Mn |
| Sep 30, 2025 | 87.52 Mn |
| Jun 30, 2025 | 79.14 Mn |
| Mar 31, 2025 | 68.53 Mn |
| Dec 31, 2024 | 75.13 Mn |
| Sep 30, 2024 | 71.68 Mn |
| Jun 30, 2024 | 70.08 Mn |
| Mar 31, 2024 | 72.24 Mn |
| Dec 31, 2023 | 74.01 Mn |
| Sep 30, 2023 | 67.15 Mn |
| Jun 30, 2023 | 63.89 Mn |
| Mar 31, 2023 | 62.39 Mn |
| Dec 31, 2022 | 72.36 Mn |
| Sep 30, 2022 | 60.62 Mn |
| Jun 30, 2022 | 69.51 Mn |
| Mar 31, 2022 | 55.60 Mn |
| Dec 31, 2021 | 63.36 Mn |
| Sep 30, 2021 | 63.45 Mn |
| Jun 30, 2021 | 349.48 Mn |